Despite the best efforts of cartoonists, mice are not little humans. In one particular way mice are superior to us because they can get the niacin they need in two ways. One is through food, like humans do, and the other is through the amino acid tryptophan, making it almost impossible for mice to become […]
Salt Lake City, UT, Thursday, October 18, 2018 –Mountain Pacific Venture Fund announced today its investment in Decoy Biosystems, a San Diego, California-based cancer immunotherapy company that was recently accepted into the Johnson & Johnson Innovation, JLABS (JLABS) life science incubator. The investment was part of a $6.0 million seed round syndicated with TY BIO […]
SALT LAKE CITY, UT (September 28, 2018) – BioUtah today announced that the board of directors has selected Kelvyn H. Cullimore Jr. as its president and CEO. Cullimore will succeed Kelly Slone, who has served in that capacity for the past three years. Cullimore comes to BioUtah with deep experience in both industry and […]
On November 1, BioUtah will be holding its 9th annual Utah Life Sciences Summit (ULSS). This is the premier conference for companies on the cutting edge of medical innovation, and provides a unique opportunity to connect with national leaders in the life sciences industry. Please join us for keynote speakers, panels, and networking opportunites that […]
Salt Lake City, August 1, 2018: Mountain Pacific Venture Partners, a Salt Lake City-based venture capital firm, has closed the first institutional investment into its debut fund, which invests in and supports innovative life science and biotech companies. The investment into Mountain Pacific Venture Fund was made by TY BIO Investment, Inc., a wholly-owned subsidiary […]
FOR IMMEDIATE RELEASE July 25, 2018 BioUtah Statement on U.S. House of Representatives Passage of Legislation to Permanently Repeal the Medical Device Tax Salt Lake City – BioUtah issued the following statement from President and CEO, Kelly Slone, regarding passage of the Protect Medical Innovation Act of 2017 (H.R. 184) in the U.S. House of […]
Biomerics LLC, a medical device contract manufacturer headquartered in Salt Lake City, UT is pleased to announce the acquisition of FutureMatrix Interventional, Inc. FMI, located in Athens, TX specializes in the design and manufacture of interventional catheters for the cardiovascular and urology markets. […]
Biomerics and ATL Technology, in a joint venture (Biomerics ATL, LLC), announced on Tuesday, April 24, 2018, that they have entered into an agreement under which together they will acquire Catheter Research Inc. (CRI)‘s assets in the Indianapolis and Costa Rica divisions. […]